Leaderboards/Systemic Sclerosis and Related Diseases

Systemic Sclerosis and Related Diseases

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Hana Štorkánová
Charles University
2
Tracy Tabib
University of Pittsburgh
3
Ai Kuzumi
The University of Tokyo
4
Consensus
Unknown
5
Stefano Di Donato
University of Leeds
6
Yehya Al-Adwi
University Medical Center Groningen
7
Saba Ghazanfar Ali
Shanghai Jiao Tong University
8
Gema María Lledó‐Ibáñez
Hospital Clínic de Barcelona
9
Hratch Baghdassarian
University of California San Diego
10
Mehrnaz Maleki-Fischbach
National Jewish Health

Papers

1
Publication in Lymphology (2024) [79 citations, W4401944900]
Lymphology|2024
79 cit.
2
Publication in The Visual Computer (2024) [55 citations, W4401009423]
The Visual Computer|2024
55 cit.
3
Publication in Arthritis Research & Therapy (2024) [52 citations, W4391647902]
Arthritis Research & Therapy|2024
52 cit.
4
Publication in Cell Reports Methods (2024) [20 citations, W4394842548]
Cell Reports Methods|2024
20 cit.
5
Publication in Seminars in Arthritis and Rheumatism (2024) [18 citations, W4400767403]
Seminars in Arthritis and Rheumatism|2024
18 cit.
6
Publication in The Visual Computer (2024) [17 citations, W4396214047]
The Visual Computer|2024
17 cit.
7
Publication in Arthritis & Rheumatology (2025) [17 citations, W4406951095]
Arthritis & Rheumatology|2025
17 cit.
8
Publication in Lara D. Veeken (2025) [7 citations, W4410973500]
Lara D. Veeken|2025
7 cit.
9
Publication in The Visual Computer (2024) [6 citations, W4405146724]
The Visual Computer|2024
6 cit.
10
Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial
Lara D. Veeken|2024
5 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Ayumi Yoshizaki
University of Tokyo Hospital
2
Mahmuda Khan
St. Elizabeth's Medical Center
3
Zhili Rong
Southern Medical University
4
Berna C. Özdemir
University Hospital of Bern
5
Zsuzsanna H. McMahan
The University of Texas Health Science Center at Houston
6
Zuo‐Lin Li
Zhongda Hospital Southeast University
7
Chiara Tani
Azienda Ospedaliera Universitaria Pisana
8
Paula Grasberger
University of Massachusetts Chan Medical School
9
Alba Santos
Harvard University
10
Sha Wu
Sinovac Biotech

Papers

1
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
BMC Biology|2022
53 cit.
2
Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array
Frontiers in Immunology|2023
37 cit.
3
Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
Genome biology|2023
36 cit.
4
Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis
JAMA Dermatology|2023
31 cit.
5
Phase-separated DropCRISPRa platform for efficient gene activation in mammalian cells and mice
Nucleic Acids Research|2023
28 cit.
6
Generation of Human Embryonic Stem Cell-Derived Lung Organoids for Modeling Infection and Replication Differences between Human Adenovirus Types 3 and 55 and Evaluating Potential Antiviral Drugs
Journal of Virology|2023
27 cit.
7
Utility of nailfold capillary assessment for predicting psoriatic arthritis based on a prospective observational cohort study
Lara D. Veeken|2022
26 cit.
8
Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagy
Cell Death and Disease|2023
26 cit.
9
Significant gastrointestinal unmet needs in patients with Systemic Sclerosis: insights from a large international patient survey
Lara D. Veeken|2023
26 cit.
10
Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphy
Lara D. Veeken|2022
23 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Thomas A. Medsger
University of Pittsburgh
2
Janet Pope
St Joseph's Health Care
3
Marco Matucci‐Cerinic
Vita-Salute San Raffaele University
4
Yannick Allanore
Inserm
5
Shinichi Sato
University of Tokyo Hospital
6
Michal Tomčík
Institute of Rheumatology
7
Oliver Distler
University Hospital of Zurich
8
Christopher P. Denton
The Royal Free Hospital
9
Jörg H. W. Distler
Düsseldorf University Hospital
10
Daniel E. Furst
University of California, Los Angeles

Papers

1
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
Scientific Reports|2021
5.1k cit.
2
2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Arthritis & Rheumatism|2013
3.4k cit.
3
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Annals of the Rheumatic Diseases|2013
2.9k cit.
4
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
New England Journal of Medicine|2019
1.6k cit.
5
Changes in causes of death in systemic sclerosis, 1972–2002
Annals of the Rheumatic Diseases|2007
1.5k cit.
6
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis
Arthritis Care & Research|2008
1.5k cit.
7
Criteria for the classification of early systemic sclerosis.
PubMed|2001
1.4k cit.
8
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
Annals of the Rheumatic Diseases|2007
922 cit.
9
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Nature Communications|2012
831 cit.
10
Mapping and predicting mortality from systemic sclerosis
Annals of the Rheumatic Diseases|2017
684 cit.

Reagents for Systemic Sclerosis and Related Diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

Acetyl-alpha-Tubulin (Lys40) (D20G3) Rabbit Monoclonal Antibody (HRP Conjugate)

#14652$493
View Evidence →
Agilent/Dako

Monoclonal Mouse Anti Human Smooth Muscle Actin

#M0851
View Evidence →
Cell Signaling Technology

c-Myb (D2R4Y) Rabbit Monoclonal Antibody

#12319$157,348
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

AML1 (D33G6) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 15 papers
#15002$465
View Evidence →
Cell Signaling TechnologyEvidence 68

alpha-Smooth Muscle Actin Antibody

Cited in 5 papers
#14968$320
View Evidence →
Cell Signaling TechnologyEvidence 62

PKC Isoform Antibody Sampler Kit

#9960$427
View Evidence →